Cargando…
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
Several oncolytic viruses (OVs) including various human and canine adenoviruses, canine distemper virus, herpes-simplex virus, reovirus, and members of the poxvirus family, such as vaccinia virus and myxoma virus, have been successfully tested for canine cancer therapy in preclinical and clinical se...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411685/ https://www.ncbi.nlm.nih.gov/pubmed/32664672 http://dx.doi.org/10.3390/v12070750 |
_version_ | 1783568435487178752 |
---|---|
author | Petrov, Ivan Gentschev, Ivaylo Vyalkova, Anna Elashry, Mohamed I. Klymiuk, Michele C. Arnhold, Stefan Szalay, Aladar A. |
author_facet | Petrov, Ivan Gentschev, Ivaylo Vyalkova, Anna Elashry, Mohamed I. Klymiuk, Michele C. Arnhold, Stefan Szalay, Aladar A. |
author_sort | Petrov, Ivan |
collection | PubMed |
description | Several oncolytic viruses (OVs) including various human and canine adenoviruses, canine distemper virus, herpes-simplex virus, reovirus, and members of the poxvirus family, such as vaccinia virus and myxoma virus, have been successfully tested for canine cancer therapy in preclinical and clinical settings. The success of the cancer virotherapy is dependent on the ability of oncolytic viruses to overcome the attacks of the host immune system, to preferentially infect and lyse cancer cells, and to initiate tumor-specific immunity. To date, several different strategies have been developed to overcome the antiviral host defense barriers. In our study, we used canine adipose-derived mesenchymal stem cells (cAdMSCs) as a “Trojan horse” for the delivery of oncolytic vaccinia virus Copenhagen strain to achieve maximum oncolysis against canine soft tissue sarcoma (CSTS) tumors. A single systemic administration of vaccinia virus-loaded cAdMSCs was found to be safe and led to the significant reduction and substantial inhibition of tumor growth in a CSTS xenograft mouse model. This is the first example that vaccinia virus-loaded cAdMSCs could serve as a therapeutic agent against CSTS tumors. |
format | Online Article Text |
id | pubmed-7411685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74116852020-08-25 Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas Petrov, Ivan Gentschev, Ivaylo Vyalkova, Anna Elashry, Mohamed I. Klymiuk, Michele C. Arnhold, Stefan Szalay, Aladar A. Viruses Article Several oncolytic viruses (OVs) including various human and canine adenoviruses, canine distemper virus, herpes-simplex virus, reovirus, and members of the poxvirus family, such as vaccinia virus and myxoma virus, have been successfully tested for canine cancer therapy in preclinical and clinical settings. The success of the cancer virotherapy is dependent on the ability of oncolytic viruses to overcome the attacks of the host immune system, to preferentially infect and lyse cancer cells, and to initiate tumor-specific immunity. To date, several different strategies have been developed to overcome the antiviral host defense barriers. In our study, we used canine adipose-derived mesenchymal stem cells (cAdMSCs) as a “Trojan horse” for the delivery of oncolytic vaccinia virus Copenhagen strain to achieve maximum oncolysis against canine soft tissue sarcoma (CSTS) tumors. A single systemic administration of vaccinia virus-loaded cAdMSCs was found to be safe and led to the significant reduction and substantial inhibition of tumor growth in a CSTS xenograft mouse model. This is the first example that vaccinia virus-loaded cAdMSCs could serve as a therapeutic agent against CSTS tumors. MDPI 2020-07-12 /pmc/articles/PMC7411685/ /pubmed/32664672 http://dx.doi.org/10.3390/v12070750 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Petrov, Ivan Gentschev, Ivaylo Vyalkova, Anna Elashry, Mohamed I. Klymiuk, Michele C. Arnhold, Stefan Szalay, Aladar A. Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title | Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title_full | Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title_fullStr | Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title_full_unstemmed | Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title_short | Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a “Trojan Horse” in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas |
title_sort | canine adipose-derived mesenchymal stem cells (cadmscs) as a “trojan horse” in vaccinia virus mediated oncolytic therapy against canine soft tissue sarcomas |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411685/ https://www.ncbi.nlm.nih.gov/pubmed/32664672 http://dx.doi.org/10.3390/v12070750 |
work_keys_str_mv | AT petrovivan canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT gentschevivaylo canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT vyalkovaanna canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT elashrymohamedi canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT klymiukmichelec canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT arnholdstefan canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas AT szalayaladara canineadiposederivedmesenchymalstemcellscadmscsasatrojanhorseinvacciniavirusmediatedoncolytictherapyagainstcaninesofttissuesarcomas |